The survival analysis in brain lower-grade glioma demonstrates a higher survival probability of individuals with medium/low expression level of ERGIC1, than in individuals with high expression levels (Figure 1, Table 1). The gene discussed is ERGIC1; the disease is central nervous system cancer.